AssetMark Inc’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
2023
Q4
$1.37M Buy
2023
Q3
$536K Buy
2023
Q2
$582K Buy
2023
Q1
$385K Buy
2022
Q4
$237K Buy
2022
Q3
$115K Buy